AstraZeneca PLC

AZN:Phase III Trial Of Sipavibart Met Main Goal In Preventing COVID-19 In Immunocompromised Patients

16 مايو 2024 03:51:29 بحسب NASDAQ US Markets

AstraZeneca To Withdraw Its Covid-19 Vaccine Vaxzevria Worldwide

08 مايو 2024 05:10:43 بحسب NASDAQ US Markets

AstraZeneca: Enhertu Improved PFS In HR-positive, HER2-low Metastatic Breast Cancer

29 أبريل 2024 02:45:52 بحسب NASDAQ US Markets

AstraZeneca's Truqap Plus Faslodex Recommended For EU Approval By CHMP For Advanced Breast Cancer

29 أبريل 2024 02:45:52 بحسب NASDAQ US Markets

AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript

25 أبريل 2024 12:52:49 بحسب NASDAQ US Markets

Nasdaq 100 Movers: META, AZN

25 أبريل 2024 11:30:48 بحسب NASDAQ US Markets

Nasdaq 100 Movers: META, AZN

25 أبريل 2024 11:15:48 بحسب NASDAQ Stocks

AstraZeneca Q1 Profit, Revenues Climb; Backs FY24 Outlook

25 أبريل 2024 03:16:35 بحسب NASDAQ US Markets

ANGLE Reaches Deal With AstraZeneca To Advance DDR Assay For Circulating Tumor Cell Detection

24 أبريل 2024 03:37:17 بحسب NASDAQ US Markets

FDA Approves AstraZeneca And Daiichi Sankyo's Enhertu For Solid Tumors Treatment

05 أبريل 2024 22:16:14 بحسب NASDAQ US Markets

Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III

05 أبريل 2024 09:38:12 بحسب NASDAQ Stocks

AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod

02 أبريل 2024 10:15:53 بحسب NASDAQ Stocks

Next-Gen Cancer Therapies Could Spark Upside for AstraZeneca Stock

26 مارس 2024 18:07:03 بحسب NASDAQ Stocks

AstraZeneca Announces FDA Approval For Ultomiris - Quick Facts

25 مارس 2024 03:55:20 بحسب NASDAQ US Markets

Fusion (FUSN) Up 99% on $2.4B Buyout Offer From AstraZeneca

20 مارس 2024 14:32:29 بحسب NASDAQ Stocks

AstraZeneca To Buy Fusion Pharma For Up To $2.4 Bln

19 مارس 2024 03:31:51 بحسب NASDAQ US Markets

AstraZeneca To Expand Savings Programs For US Inhaled Respiratory Portfolio

18 مارس 2024 07:40:23 بحسب NASDAQ US Markets

First Week of AZN May 17th Options Trading

15 مارس 2024 12:39:15 بحسب NASDAQ Stocks

AstraZeneca To Buy Amolyt Pharma For Up To $1.05 Bln To Expand Late-stage Rare Disease Pipeline

14 مارس 2024 03:46:14 بحسب NASDAQ US Markets

AstraZeneca Announces Initiation Of Phase III Trial With BREZTRI

13 مارس 2024 07:41:44 بحسب NASDAQ US Markets